Stomach Cancer Trial, Recruiting NCT06760858 Sponsor: Southwest Hospital, China Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06760858
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been newly diagnosed with a type of stomach cancer called gastric adenocarcinoma that is HER-2 negative, and you have not had any cancer treatments (such as chemotherapy or radiation) before joining.
  • You are between 18 and 80 years old and are generally able to carry out daily activities with little or no limitation.
  • Your cancer is at a specific stage (T4aNxM0 according to medical staging guidelines), meaning it has grown into nearby tissue but has not spread to distant parts of the body, and is not causing blockages, tears, or bleeding.
  • Your blood counts are within acceptable ranges, showing your bone marrow is working well enough (confirm with trial site for exact values).
  • Your liver and kidney function test results are within acceptable limits (confirm with trial site for exact values).
  • Your blood clotting tests are within acceptable ranges (confirm with trial site).
  • Your urine protein levels are low enough, or if slightly elevated, a 24-hour urine test shows they are within an acceptable limit.
  • You agree to provide blood and tissue samples for the study.
  • You are expected to live for more than 3 months.
  • If you are a woman who could become pregnant, you agree to use strict contraception during the study; if you are a man whose partner could become pregnant, you agree to use effective contraception during the study.
  • You are willing to sign a consent form and follow all trial visits, treatments, and procedures.

Who may not be able to join:

  • You are currently in another clinical drug trial or have taken part in one within the last month.
  • You have received any other cancer treatments (such as chemotherapy, radiation, surgery, or immunotherapy) other than what is being studied in this trial.
  • You have previously used similar chemotherapy drugs or medicines that work on the immune system in a similar way (called immune checkpoint inhibitors).
  • Your cancer has spread to other parts of the body, such as the liver, lungs, bones, brain, adrenal glands, or other areas of the abdomen or pelvis.
  • You have had a tear or blockage in your digestive system, or uncontrollable diarrhea, within the past 6 months.
  • You currently have another cancer that is untreated or being treated at the same time, with some exceptions for certain minor or fully cured cancers (confirm with trial site).
  • You have a symptomatic (causing symptoms) meningioma (a type of brain or spinal cord tumour) (confirm with trial site).
  • You have a history of active or difficult-to-treat autoimmune disease (where the immune system attacks the body).
  • You have taken steroid medications above a certain dose, or other medicines that suppress the immune system, within the last 14 days (some exceptions apply — confirm with trial site).
  • You have HIV or an active hepatitis B or C infection.
  • You have an ongoing serious bacterial, fungal, or viral infection.
  • You have significant heart problems, such as heart failure, active coronary artery disease, certain irregular heart rhythms, or unstable chest pain; or you have had a heart attack with unhealed wounds or fractures within the past 6 months.
  • Your kidneys are failing and you need dialysis.
  • You are taking medication to control epilepsy (seizures).
  • You have had an organ or tissue transplant in the past, including a corneal (eye) transplant.
  • You are allergic or may be allergic to the study drug or similar medicines.
  • You are pregnant or breastfeeding.
  • You have had major surgery or a significant injury within the past 4 weeks.
  • You have received a vaccination within the past 4 weeks.
  • The trial doctor does not consider you suitable for the study for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13752909448

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Southwest Hospital, China
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 September 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

3-year disease-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov